|Articles|December 8, 2016
New CEO for Muse bio
December 08, 2016
Advertisement
Muse bio (Boulder, CO) announced that Dr. Kevin Ness has been appointed Chief Executive Officer and member of the Board of Directors.
Prior to joining Muse bio, Dr. Ness was co-founder, Chief Technology Officer and Chief Operating Officer of 10X Genomics. Previously, he co-founded and was Vice President of Product Development at QuantaLife, acquired by Bio-RAD in 2011.
He succeeds Muse bio's founding CEO Ryan Gill, who becomes the company's Chief Science Officer.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5